Terazosin
Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH).
Trivial name | Fosfomic |
Catalog Number | CSN16773 |
Alternative Name(s) | Fosfomic |
Research Area | Metabolic Disease |
Molecular Formula | C19H25N5O4 |
CAS# | 63590-64-7 |
Purity | ≥98% |
SMILES | O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4 |
Size | 100mg |
Supplier Page | https://www.csnpharm.com/products/terazosin.html |